277 related articles for article (PubMed ID: 6262150)
1. Herd effect and virus eradication with use of killed poliovirus vaccine.
Salk D
Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
[TBL] [Abstract][Full Text] [Related]
2. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
3. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
Salk J
Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
[TBL] [Abstract][Full Text] [Related]
4. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
5. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
6. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
7. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
8. Poliomyelitis vaccination benefits--versus risk.
Assaad F
Dev Biol Stand; 1979; 43():141-50. PubMed ID: 520666
[TBL] [Abstract][Full Text] [Related]
9. Current status of the global eradication of poliomyelitis.
Tangermann RH; Aylward B; Birmingham M; Horner R; Olivé JM; Nkowane BM; Hull HF; Burton A
World Health Stat Q; 1997; 50(3-4):188-94. PubMed ID: 9477548
[TBL] [Abstract][Full Text] [Related]
10. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
11. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
[No Abstract] [Full Text] [Related]
12. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of poliomyelitis--options and update.
Dutta A
Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
[TBL] [Abstract][Full Text] [Related]
14. Advantages and disadvantages of killed and live poliomyelitis vaccines.
Melnick JL
Bull World Health Organ; 1978; 56(1):21-38. PubMed ID: 307445
[TBL] [Abstract][Full Text] [Related]
15. Criteria for control of infectious diseases with poliomyelitis as an example.
Evans AS
Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
[No Abstract] [Full Text] [Related]
16. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
[TBL] [Abstract][Full Text] [Related]
17. [Poliomyelitis in The Netherlands, 1979-1991: immunity and exposure].
Rümke HC; Oostvogel PM; van der Veer M; van Steenis G; van Loon AM
Ned Tijdschr Geneeskd; 1993 Jul; 137(28):1380-6. PubMed ID: 8240513
[TBL] [Abstract][Full Text] [Related]
18. Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(4):97-9. PubMed ID: 16456525
[TBL] [Abstract][Full Text] [Related]
19. Polio endgame. Polio: The final assault?
Roberts L
Science; 2004 Mar; 303(5666):1960-8. PubMed ID: 15044779
[No Abstract] [Full Text] [Related]
20. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
